2.5 mg retatrutide 🎙️ NEW EPISODE: Retatrutide—The Triple Agonist *Not licensed* Will this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in A Clinician's Guide to Retatrutide

In response to the clean label movement, companies are looking for natural sources of fermented glutathione as opposed to synthetic sources

Comparative analysis of PRAME expression in 127 acral and nail melanocytic lesions

The North American Neuro-Ophthalmology Society and the American Academy of Ophthalmology did distinguish that discontinuing GLP-1 therapy could pose significant health risks for some patients, such as those with obesity, those whose diabetes has been difficult to manage with other therapies or those with cardiovascular comorbidities

Nextech simplifies referrals to nutritionists, dietitians, and other providers who will play an important role in helping your patients adjust to their healthy new lifestyle

It requires a lot of commitment so I can make a lifelong change